Robin E. B. Lee

729 total citations
8 papers, 533 citations indexed

About

Robin E. B. Lee is a scholar working on Infectious Diseases, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Robin E. B. Lee has authored 8 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Organic Chemistry and 4 papers in Molecular Biology. Recurrent topics in Robin E. B. Lee's work include Synthesis and Biological Evaluation (3 papers), Synthesis and biological activity (2 papers) and Tuberculosis Research and Epidemiology (2 papers). Robin E. B. Lee is often cited by papers focused on Synthesis and Biological Evaluation (3 papers), Synthesis and biological activity (2 papers) and Tuberculosis Research and Epidemiology (2 papers). Robin E. B. Lee collaborates with scholars based in United States. Robin E. B. Lee's co-authors include Richard Lee, Teresa T. Liu, P. David Rogers, Katherine S. Barker, Ramin Homayouni, Lai Wei, Rajendra Tangallapally, Anne J. Lenaerts, Dianqing Sun and Nageshwar Budha and has published in prestigious journals such as Analytical Chemistry, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Robin E. B. Lee

8 papers receiving 520 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robin E. B. Lee United States 7 280 208 169 154 81 8 533
Manpreet Kaur Rawal India 13 251 0.9× 197 0.9× 212 1.3× 73 0.5× 86 1.1× 16 534
Jie Tu China 16 322 1.1× 232 1.1× 192 1.1× 240 1.6× 47 0.6× 33 646
Chiatogu Onyewu United States 7 392 1.4× 199 1.0× 246 1.5× 59 0.4× 78 1.0× 7 530
Charles Gill United States 13 267 1.0× 328 1.6× 189 1.1× 98 0.6× 94 1.2× 22 747
Lynn Miesel United States 17 307 1.1× 440 2.1× 203 1.2× 109 0.7× 51 0.6× 28 825
Stella Z. Doktor United States 14 164 0.6× 316 1.5× 193 1.1× 51 0.3× 78 1.0× 21 665
Arielle Butts United States 12 333 1.2× 143 0.7× 263 1.6× 82 0.5× 57 0.7× 16 498
Jiuyu Liu United States 14 323 1.2× 388 1.9× 166 1.0× 170 1.1× 36 0.4× 42 736
V.B. Pikounis United States 6 519 1.9× 210 1.0× 346 2.0× 88 0.6× 118 1.5× 7 764
Patricia Torres United States 5 391 1.4× 354 1.7× 231 1.4× 341 2.2× 74 0.9× 8 1.0k

Countries citing papers authored by Robin E. B. Lee

Since Specialization
Citations

This map shows the geographic impact of Robin E. B. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin E. B. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin E. B. Lee more than expected).

Fields of papers citing papers by Robin E. B. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin E. B. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin E. B. Lee. The network helps show where Robin E. B. Lee may publish in the future.

Co-authorship network of co-authors of Robin E. B. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Robin E. B. Lee. A scholar is included among the top collaborators of Robin E. B. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin E. B. Lee. Robin E. B. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Tangallapally, Rajendra, Dianqing Sun, Rakesh Rakesh, et al.. (2007). Discovery of novel isoxazolines as anti-tuberculosis agents. Bioorganic & Medicinal Chemistry Letters. 17(23). 6638–6642. 84 indexed citations
2.
Sun, Dianqing, Victoria Jones, Robin E. B. Lee, et al.. (2007). Solid-phase synthesis and biological evaluation of a uridinyl branched peptide urea library. Bioorganic & Medicinal Chemistry Letters. 17(24). 6899–6904. 24 indexed citations
3.
Tangallapally, Rajendra, Robin E. B. Lee, Anne J. Lenaerts, & Richard Lee. (2006). Synthesis of new and potent analogues of anti-tuberculosis agent 5-nitro-furan-2-carboxylic acid 4-(4-benzyl-piperazin-1-yl)-benzylamide with improved bioavailability. Bioorganic & Medicinal Chemistry Letters. 16(10). 2584–2589. 38 indexed citations
4.
5.
Lee, Robin E. B., Teresa T. Liu, Katherine S. Barker, Richard Lee, & P. David Rogers. (2005). Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans. Journal of Antimicrobial Chemotherapy. 55(5). 655–662. 44 indexed citations
6.
Li, Wěi, Robin E. B. Lee, Richard Lee, & Jinghu Li. (2005). Methods for Acquisition and Assignment of Multidimensional High-Resolution Magic Angle Spinning NMR of Whole Cell Bacteria. Analytical Chemistry. 77(18). 5785–5792. 27 indexed citations
7.
Liu, Teresa T., Robin E. B. Lee, Katherine S. Barker, et al.. (2005). Genome-Wide Expression Profiling of the Response to Azole, Polyene, Echinocandin, and Pyrimidine Antifungal Agents inCandida albicans. Antimicrobial Agents and Chemotherapy. 49(6). 2226–2236. 259 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026